Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Sept 2026 for Opus Genetics, Inc., €107k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Gagnon Robert E.: trading record in brief
Gagnon Robert E. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Opus Genetics, Inc. and Verastem, Inc. In total, 4 filings cover trades dated from 25 June 2026 to 3 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 3 September 2026: a transaction of €107k, in Opus Genetics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gagnon Robert E.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
28,000 shares@ US$4.450.0054% mcap58.7% of flowCommonSEC144:0001974158-26-000100
7,783 shares@ US$3.050.0012% mcap37.4% of flowCommonSEC144:0001974158-26-000091
31,924 shares@ US$5.890.036% mcap25.6% of flowCommonSEC144:0001974158-26-000089
21,492 shares@ US$4.210.014% mcap16.7% of flowCommonSEC144:0001974158-26-000075
4 of 4 declarations
